Disrupted Microbial Homeostasis and Host Immunity: Unraveling the Mechanistic Links in Dysbiosis

Grewel Jhosph^*
*Correspondence: Grewel Jhosph, Department of Hematology, Saga University, Saga, Japan, Email:

Introduction

The human microbiome plays a fundamental role in maintaining health by supporting digestion, producing essential metabolites, and shaping immune system function. A balanced microbial ecosystem, particularly in the gut, is essential for immune tolerance, defense against pathogens, and regulation of inflammation. However, disruptions to this microbial equilibriumâ??a state known as dysbiosisâ??have been increasingly linked to a wide range of diseases, including inflammatory bowel disease, metabolic disorders, autoimmune conditions, and cancer. Despite extensive associative evidence, the mechanistic underpinnings connecting microbial imbalance to immune dysfunction remain poorly understood. Understanding how dysbiosis perturbs host-microbial interactions and immune regulation is critical to elucidating disease pathogenesis and developing targeted therapeutic strategies [1].

Description

In this study, we explore the mechanistic links between microbial dysbiosis and host immune responses by integrating data from gnotobiotic animal models, microbiome sequencing, and host transcriptomic profiling [2]. Using both germ-free and antibiotic-treated mice colonized with human-derived microbiota, we investigate how specific alterations in microbial composition influence mucosal immune signaling, epithelial barrier integrity, and systemic inflammatory markers. Our findings reveal that loss of microbial diversity and depletion of key commensal taxa, such as Faecalibacterium prausnitzii and Bacteroides fragilis, are associated with impaired regulatory T cell (Treg) function and enhanced pro-inflammatory cytokine production, including IL-6, IL-17, and TNF-α. These immune perturbations are accompanied by compromised intestinal barrier function and increased translocation of microbial products into circulation, further fueling systemic immune activation [3].

Metagenomic and metabolomic analyses demonstrate that dysbiosis also leads to altered microbial metabolic output, including reduced production of Short-Chain Fatty Acids (SCFAs) such as butyrate, which are known to support Treg differentiation and epithelial health [4]. Restoration of microbial balance through targeted probiotic administration or Fecal Microbiota Transplantation (FMT) partially reverses immune dysregulation, highlighting the causal role of specific microbial functions in maintaining immune homeostasis. Additionally, we identify microbial signatures that correlate with immune cell infiltration and gene expression patterns in mucosal tissues, providing molecular insight into how microbial communities modulate host immune networks [5].

Conclusion

In conclusion, this study elucidates key mechanisms by which disrupted microbial homeostasis contributes to immune dysregulation and chronic inflammation. By linking specific microbial taxa and metabolites to defined immunological outcomes, the findings offer a deeper understanding of host-microbe interactions in health and disease. These insights underscore the importance of maintaining microbial diversity and functional capacity in supporting immune balance and suggest novel microbiome-based strategies for the prevention and treatment of immune-mediated disorders. As our knowledge of microbiota-immunity crosstalk expands, therapeutic modulation of the microbiome emerges as a promising avenue to restore immune homeostasis in dysbiosis-associated diseases.

Acknowledgment

None.

Conflict of Interest

None.

References

1. Hacker, Karen. "The burden of chronic disease." Mayo Clin Proc Innov Qual Outcomes8 (2024): 112-119.

Google Scholar Cross Ref Indexed at

2. Di Cesare, Mariachiara, Pablo Perel, Sean Taylor and Chodziwadziwa Kabudula, et al. "The heart of the world." Glob Heart19 (2024): 11.

Google Scholar Cross Ref Indexed at

3. Sung, Hyuna, Jacques Ferlay, Rebecca L. Siegel and Mathieu Laversanne, et al. "Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries." CA A Cancer J Clin 71 (2021): 209-249.

Google Scholar Cross Ref

4. Soriano, Joan B., Parkes J. Kendrick, Katherine R. Paulson and Vinay Gupta, et al. "Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017." Lancet Respir Med 8 (2020): 585-596.

Google Scholar Cross Ref Indexed at

5. Ong, Kanyin Liane, Lauryn K. Stafford, Susan A. McLaughlin and Edward J. Boyko, et al. "Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021." Lancet 402 (2023): 203-234.

Google Scholar Cross Ref